Generation of an induced pluripotent stem cell line (TRNDi031-A) from a patient with Alagille syndrome type 1 carrying a heterozygous p. C312X (c. 936 T>A) mutation in JAGGED-1

被引：2
|
作者：
Brooks, Brianna M. [1 ]
Pradhan, Manisha [1 ]
Cheng, Yu-Shan [1 ]
Gorshkov, Kirill [1 ]
Farkhondeh, Atena [1 ]
Chen, Catherine Z. [1 ]
Beers, Jeanette [2 ]
Liu, Chengyu [3 ]
Baumgaertel, Karsten [4 ]
Rodems, Steven [4 ]
Zheng, Wei [1 ]
机构：
[1] Natl Ctr Adv Translat Sci, NIH, 9800 Med Ctr Dr, Bethesda, MD 20892 USA
[2] NHLBI, iPSC Core, NIH, Bldg 10, Bethesda, MD 20892 USA
[3] NHLBI, Transgen Core, NIH, Bldg 10, Bethesda, MD 20892 USA
[4] Travere Therapeut, San Diego, CA USA
来源：
STEM CELL RESEARCH | 2021年 / 54卷
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/j.scr.2021.102447
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Alagille syndrome (ALGS) is a rare autosomal dominant disorder caused by disruption of the Notch signaling pathway due to mutations in either JAGGED1 (JAG1) (ALGS type 1) or NOTCH2 (ALGS type 2). Loss of this signaling interferes with the development of many organs, but especially the liver. A human induced pluripotent stem cell (iPSC) line was generated from the fibroblasts of a patient with a p. C312X (c. 936 T > A) variant in JAG1. This iPSC line offers a valuable resource to study the disease pathophysiology and develop therapeutics to treat patients with ALGS.
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Generation of an induced pluripotent stem cell line (TRNDi004-I) from a Niemann-Pick disease type B patient carrying a heterozygous mutation of p.L43_A44delLA in the SMPD1 gene
    Baskfield, Amanda
    Li, Rong
    Beers, Jeanette
    Zou, Jizhong
    Liu, Chengyu
    Zheng, Wei
    STEM CELL RESEARCH, 2019, 37
  • [32] Establishment of an induced pluripotent stem cell line (NCKDi003-A) from a patient with X-linked Dent disease (X-Dent) carrying the hemizygote mutation p. T277P (c. 829A > C) in the CLCN5 gene
    Hu, Lidan
    Wang, Gang
    Wu, Hangdi
    Fu, Haidong
    Wang, Yan
    Yu, Fan
    Liu, Zhihong
    Mao, Jianhua
    STEM CELL RESEARCH, 2021, 56
  • [33] Human induced pluripotent stem cells derived from a patient with a mutation of FBN1c.1858C > T (p. Pro620Ser)
    Lin, Aiqi
    Kang, Xiaocui
    Xu, Yi
    Feng, Xiaochao
    Zhang, Shufan
    Zhao, Hongchen
    Wu, Danhong
    Han, Xiang
    STEM CELL RESEARCH, 2022, 61
  • [34] Reprogramming of a human induced pluripotent stem cell line from a long QT syndrome patient harboring a heterozygous mutation of c.1537C > T in SCN5A gene
    Chen, Jianan
    Song, Yesang
    Gu, Junqing
    Chen, Lian
    STEM CELL RESEARCH, 2021, 57
  • [35] Generation of a human induced pluripotent stem cell (iPSC) line from a patient carrying a P33T mutation in the PDX1 gene
    Wang, Xianming
    Chen, Shen
    Burtscher, Ingo
    Sterr, Michael
    Hieronimus, Anja
    Machicao, Fausto
    Staiger, Harald
    Haering, Hans-Ulrich
    Lederer, Gabriele
    Meitinger, Thomas
    Lickert, Heiko
    STEM CELL RESEARCH, 2016, 17 (02) : 273 - 276
  • [36] Generation of an induced pluripotent stem cell line (TRNDi002-B) from a patient carrying compound heterozygous p.Q208X and p.G310G mutations in the NGLY1 gene
    Li, Rong
    Pradhan, Manisha
    Xu, Miao
    Baskfield, Amanda
    Farkhondeh, Atena
    Cheng, Yu-Shan
    Beers, Jeanette
    Zou, Jizhong
    Liu, Chengyu
    Might, Matthew
    Rodems, Steven
    Zheng, Wei
    STEM CELL RESEARCH, 2019, 34
  • [37] Generation of an induced pluripotent stem cell line (SJTUGHi001-A) from a patient with Retinitis Pigmentosa carrying c.77C > T mutation in RAX2 gene
    Bai, Xinyue
    Chen, Jieqiong
    Zhao, Xiaohuan
    Zhu, Xinyue
    Ding, Xiaoyan
    Zhang, Ting
    Jiang, Mei
    Sun, Xiaodong
    STEM CELL RESEARCH, 2024, 77
  • [38] Generation of a human induced pluripotent stem cell line ZZUNEUi030-A from a female patient carrying a heterozygous CALM2 (c.395 A > T) mutation
    Hua, Chongpei
    Sun, Wenrui
    Zhang, Chunjin
    Tian, Xiaoxu
    Qin, Xintong
    Dong, Jianzeng
    Li, Xiaowei
    STEM CELL RESEARCH, 2024, 81
  • [39] Establishment of a human induced pluripotent stem cell line (WMUi031-A) from a Lowe syndrome patient carrying a OCRL gene mutation (c.2626dupA)
    Qian, Rengchen
    Wang, Long
    Chen, Huihui
    Ding, Yinjuan
    Wang, Dexuan
    Chen, Congde
    Chu, Maoping
    Shan, Xiaoou
    Guo, Xiaoling
    STEM CELL RESEARCH, 2021, 53
  • [40] Generation of the human induced pluripotent stem cell line (IBKMOLi003-A) from PBMCs of a vascular Ehlers-Danlos syndrome (vEDS) patient carrying the heterozygous nonsense mutation c.430C > T (p.Q105*) in the COL3A1 gene
    Hoepperger, Sabrina
    Spathopoulou, Angeliki
    Mayer-Suess, Lukas
    Suarez-Cubero, Marta
    Sillaber, Katharina
    Spreiz, Ana
    Kiechl, Stefan
    Edenhofer, Frank
    Fellner, Lisa
    STEM CELL RESEARCH, 2024, 75
12345